| answer text |
<p>Research is crucial in tackling cancer, which is why the Department invests £1.3
billion per year in health research through the National Institute for Health and
Care Research (NIHR). The NIHR's research expenditure for all cancers was £121.8 million
in 2022/23, and the NIHR spends more on cancer than any other disease group.</p><p>The
NIHR funded nine research projects on pancreatic cancer since 2018/19, with a committed
funding value of £4.3 million.</p><p>The following table shows NIHR spending on pancreatic
cancer research for the period April 2018 to March 2023, based on contracted funding
over this period, correct as of 29 April 2024:</p><table><tbody><tr><td><p>Year commenced</p></td><td><p>Pancreatic
cancer research awards actual spending</p></td></tr><tr><td><p>2018/19</p></td><td><p>£545,000</p></td></tr><tr><td><p>2019/20</p></td><td><p>£525,000</p></td></tr><tr><td><p>2020/21</p></td><td><p>£348,000</p></td></tr><tr><td><p>2021/22</p></td><td><p>£145,000</p></td></tr><tr><td><p>2022/23</p></td><td><p>£735,000</p></td></tr><tr><td><p>Total</p></td><td><p>£2.3
million</p></td></tr></tbody></table><p>In addition, NIHR Biomedical Research Centres
and NIHR Clinical Research Facilities spent a further £6.5 million between 2018/19
and 2022/23 supporting an annual portfolio of around 85 early clinical studies in
pancreatic cancer.</p><p>The NIHR also supports delivery in the health and care system
of research into pancreatic cancer, funded by research funding partners in the charity
and public sectors. Since 2018/19 the NIHR supported 73 clinical research studies
through the Clinical Research Network.</p><p>The NIHR funds research in response to
proposals received from scientists rather than allocating funding to specific disease
areas. The NIHR welcomes funding applications for research into any aspect of human
health, including pancreatic cancer. It is not usual practice to ring-fence funds
for particular topics or conditions. Applications are subject to peer review and judged
in open competition, with awards being made on the basis of the importance of the
topic to patients and health and care services, value for money and scientific quality.</p>
|
|
